BSE: JBCHEPHARM - J. B. Chemicals & Pharmaceuticals Limited

Rentabilidad a seis meses: -20.19%
Rendimiento de dividendos: +0.73%

Calendario de promoción J. B. Chemicals & Pharmaceuticals Limited


Acerca de la empresa J. B. Chemicals & Pharmaceuticals Limited

J. B. Chemicals & Pharmaceuticals Limited manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (API) in India and internationally. The company's API product portfolio includes diclofenac sodium, diethylamine, acid, and potassium; nifedipine, atenolol, and cilnidipine; and ciprofloxacin, cetirizine, and meclizine HCI.

más detalles
It also provides dosage forms, such as tablets, lozenges, injectables, gels, creams, ointments, liquid herbal syrups, cold rubs, eye drops, troches, and capsules; and soft-centered, powder, medicated, and herbal lozenges, as well as various pharmaceutical dosage forms. In addition, it offers a range of contrast media products, including x-ray, magnetic resonance imaging (MRI), and ultrasound scanners; and contract manufacturing services. The company provides its products in gastroenterology, anti-infectives, wound care, neonatology and pediatrics, gynaecology, dental, vitamins and minerals, hypertension, diabetes, nephrology, respiratory, pain-analgesic, dermatology, antivirals, lozenges, and contrast media and radio diagnostic therapeutic areas. J. B. Chemicals & Pharmaceuticals Limited was incorporated in 1976 and is headquartered in Mumbai, India.

ISIN INE572A01028
Industry Pharmaceuticals
Sector Health Care
Валюта inr
Валюта отчета inr
Див.доход ао 0.6872
Дивиденд ао 15.25
Сайт https://www.jbpharma.com
Цена ао 1518
Cambio de precio por semana.: -3.77% (1577.4)
Cambio de precio por mes: -6.72% (1627.3)
Cambio de precio en 3 meses.: -17.54% (1840.85)
Cambio de precio en seis meses: -20.19% (1902)
Cambio de precio por año: -2.02% (1549.25)
Cambio de precio en 3 años.: -3.32% (1570.1)
Cambio de precio en 5 años.: +205.74% (496.5)
Cambio de precio desde principios de año.: -18.64% (1865.7)

Subestimación

Nombre Significado Calificación
P/S 7.25 1
P/BV 8.55 1
P/E 45.21 3
EV/EBITDA 5.46 9
Total: 5.13

Eficiencia

Nombre Significado Calificación
ROA, % 14.64 4
ROE, % 20.45 7
Total: 6.33

Dividendos

Nombre Significado Calificación
Div yield, % 0.729 1.83
DSI 0.8571 8.57
Total: 3.75

Deber

Nombre Significado Calificación
Debt/EBITDA 0.124 10
Total: 9.8

Impulso de crecimiento

Nombre Significado Calificación
Rentabilidad Revenue, % 97.83 9
Rentabilidad Ebitda, % 731 10
Rentabilidad EPS, % 106.67 10
Total: 9.8

Supervisor Título profesional Pago año de nacimiento
Mr. Nikhil Ashokkumar Chopra CEO & Whole-Time Director 65.45M 1973 (52 año)
Mr. Kunal Khanna President of Operations N/A 1980 (45 años)
Mr. Sridhar Bharadwaj Vice President of HR & Administration N/A 1967 (58 años)
Mr. Pradeep Kumar Singh President of Global Business N/A 1964 (61 año)
Mr. Himanshu Ranvah Vice President of Legal N/A 1985 (40 años)
Mr. Parmeshwar B. Bang Executive Vice President of Operations of Daman N/A 1968 (57 años)
Suresh Amin Assistant Vice President ? Human Resource
Mr. Narayan Saraf Chief Financial Officer 1980 (45 años)
Mr. Bhagwat Singh Deora Vice President of Finance & Accounts 1982 (43 año)
Mr. Suresh Bhise Vice President of Information & Technology 1966 (59 años)

DIRECCIÓN: India, Mumbai, Cnergy IT Park - abrir en mapas de google, abrir mapas de Yandex
Sitio web: https://www.jbpharma.com